VenCoM.01 study
Study Start Date: 26 January 2023
Study Completion Date: 31 December 2024
Status: recruitment completed (enrolled 70 patients)
Sponsor: Tre Esse Progettazione Biomedica s.r.l.
Clinical Study Centre: Cardiac Insufficiency and Transplantation Unit, IRCCS – Azienda Ospedaliero-Universitaria of Bologna
Primary Endpoint: to verify the concordance between non-invasive VenCoM measurement and invasive CVP measurement via catheterization (clinical gold standard)
Secondary Endpoint: to evaluate correlations between non-invasive VenCoM measurements and standard ultrasound-based measurements
Clinical evidence
- Study Start Date: 26 January 2023
- Study Completion Date: 31 December 2024
- Status: recruitment completed (enrolled 70 patients)
- Sponsor: Tre Esse Progettazione Biomedica s.r.l.
- Clinical Study Centre: Cardiac Insufficiency and Transplantation Unit, IRCCS – Azienda Ospedaliero-Universitaria of Bologna
- Primary Endpoint: to verify the concordance between non-invasive VenCoM measurement and invasive CVP measurement via catheterization (clinical gold standard)
- Secondary Endpoint: to evaluate correlations between non-invasive VenCoM measurements and standard ultrasound-based measurements
